Prevalent Occurrence of Diseases is Expanding the Global Companion Diagnostic Market
“According to a new market research report published by Inkwood Research, the Global Companion Diagnostic Market is projected to rise at a CAGR of 18.45% throughout the forecasting years of 2019-2027.”
“Browse 37 market Data Tables and 23 Figures spread over 100 Pages, along with an in-depth TOC on Global Companion Diagnostic Market Forecast 2019-2027.”
Companion diagnostic is an in vitro device used in medical tools. It helps in determining the ways certain drugs could affect a person with a particular disease. They assist physicians in making clinical decisions, gauge appropriate treatment by identifying the patient subgroups. It procures crucial information for protected and efficient use of an interrelated drug or biological product and to what extent the benefits counterbalance the potential risks. The primary drivers of this market are symbolic collaborations and partnerships for companion diagnostic test development.
Escalating Occurrence of Cancer Steers Growth in the Global Companion Diagnostic Market
Cancer is the second deadly disease. However, it engages a lot of investment from the government of various nations, research and development institution, pharma companies for new product and technology development. There exists a necessity to procreate efficient drugs and treatment for this disease. Companion diagnostics assist the doctors in concluding a specific methodology for effective and precise treatment of the patient. It further helps in deriving the associated risks and benefits of the treatment being used for the patient.
To know more about this report, request a free sample copy.
Oncology is the Leading Indicator of Diseases in the Global Companion Diagnostic Market
Oncology refers to the prevention, diagnosis and treatment of cancer. The expanding occurrence of cancer calls for the development of effective drugs and technology. Companion diagnostic in oncology assists in stipulating specific drug development through clinical traits, which are helpful in targeted immune therapy, drug therapy and hormone therapy. It further aids the oncologist in determining the appropriate treatment or drug for the patients suffering from various types of cancers.
North America Reigns the Global Companion Diagnostic Market
North America is anticipated to hold the largest share in the global companion diagnostic market. Supportive government initiatives, together with collaboration between major companies, has fueled the growth of the global companion diagnostic market in the region. Also, the upsurging cases of cancer are anticipated to surge the market demand in North America.
The prevalence of diseases such as cancer, other infectious diseases will create a market for new companies. The market is highly competitive, and the companies are continually engaging in mergers, acquisitions, collaboration and partnerships to sustain their presence in the market. The threat of substitutes is medium or low, but the entry of new players will lead to development of new and better technologies. The present prominent players include Abbott companies, Almac, Biocartis, GE Healthcare, etc.
About Inkwood Research
Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy; with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises of North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.